Currently, therapeutic options for stroke, Parkinson’s disease and neuropathic pain syndromes are sparse, not evidence-based but based on general concepts. This results in unnecessary long-lasting disability and loss of autonomy. This is in sharp contrast to one of the most important insights of the last decades that the human brain is highly flexible and can change function. This adaptive capacity of the human nervous system is called neuroplasticity.
NeuroControl focuses on exploiting neuroplasticity as the key towards the development of innovative tools for treatment and prevention of disabilities caused by chronic neurological diseases. To exploit neuroplasticity, novel diagnostic and therapeutic means will be developed by matching control-engineering with neuroscience, signal-processing with neurology, and robotics with rehabilitation medicine.